| Adverse drug reactions in elderly patients PA Routledge, MS O'mahony, KW Woodhouse British journal of clinical pharmacology 57 (2), 121-126, 2004 | 693 | 2004 |
| Managing the challenge of chemically reactive metabolites in drug development BK Park, A Boobis, S Clarke, CEP Goldring, D Jones, JG Kenna, ... Nature Reviews Drug Discovery 10 (4), 292-306, 2011 | 481 | 2011 |
| Patient reporting of suspected adverse drug reactions: a review of published literature and international experience A Blenkinsopp, P Wilkie, M Wang, PA Routledge British journal of clinical pharmacology 63 (2), 148-156, 2007 | 416 | 2007 |
| Intravenous adenosine in the treatment of supraventricular tachycardia: a dose‐ranging study and interaction with dipyridamole. AH Watt, MS Bernard, J Webster, SL Passani, MR Stephens, ... British journal of clinical pharmacology 21 (2), 227-230, 1986 | 267 | 1986 |
| Important drug-drug interactions in the elderly RM Seymour, PA Routledge Drugs & aging 12, 485-494, 1998 | 253 | 1998 |
| Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial IA Campbell, DP Bentley, RJ Prescott, PA Routledge, HGM Shetty, ... Bmj 334 (7595), 674, 2007 | 238 | 2007 |
| Clinical pharmacokinetics of propranolol. PA Routledge, DG Shand Clinical pharmacokinetics 4 (2), 73-90, 1979 | 217 | 1979 |
| The plasma protein binding of basic drugs. PA Routledge British journal of clinical pharmacology 22 (5), 499-506, 1986 | 215 | 1986 |
| Flexible induction dose regimen for warfarin and prediction of maintenance dose. A Fennerty, J Dolben, P Thomas, G Backhouse, DP Bentley, IA Campbell, ... Br Med J (Clin Res Ed) 288 (6426), 1268-1270, 1984 | 213 | 1984 |
| 150 years of pharmacovigilance P Routledge The Lancet 351 (9110), 1200-1201, 1998 | 206 | 1998 |
| Benzodiazepines, Z-drugs and the risk of hip fracture: A systematic review and meta-analysis K Donnelly, R Bracchi, J Hewitt, PA Routledge, B Carter PloS one 12 (4), e0174730, 2017 | 202 | 2017 |
| Lidocaine plasma protein binding PA Routledge, A Barchowsky, TD Bjornsson, BB Kitchell, DG Shand Clinical Pharmacology & Therapeutics 27 (3), 347-351, 1980 | 185 | 1980 |
| Effective Reversal of Warfarin-lnduced Excessive Anticoagulation With Low Dose Mtamin K1 HGM Shetty, G Backhouse, DP Bentley, PA Routledge Thrombosis and haemostasis 67 (01), 013-015, 1992 | 155 | 1992 |
| The use of herbal medicines by people with cancer: a cross-sectional survey S Damery, C Gratus, R Grieve, S Warmington, J Jones, P Routledge, ... British journal of cancer 104 (6), 927-933, 2011 | 128 | 2011 |
| Changing patterns of self-poisoning in a UK health district MC Bialas, PG Reid, P Beck, JH Lazarus, PM Smith, RC Scorer, ... QJM: An International Journal of Medicine 89 (12), 893-902, 1996 | 127 | 1996 |
| Increased alpha-1-acid glycoprotein and lidocaine disposition in myocardial infarction PA ROUTLEDGE, WW STARGEL, GS WAGNER, DG SHAND Annals of Internal Medicine 93 (5), 701-704, 1980 | 127 | 1980 |
| Pulmonary function, body composition, and protein catabolism in adults with cystic fibrosis AA Ionescu, LS Nixon, S Luzio, V Lewis-Jenkins, WD Evans, MD Stone, ... American journal of respiratory and critical care medicine 165 (4), 495-500, 2002 | 125 | 2002 |
| Factors affecting warfarin requirements: a prospective population study PA Routledge, PH Chapman, DM Davies, MD Rawlins European Journal of Clinical Pharmacology 15, 319-322, 1979 | 118 | 1979 |
| The use of herbal medicines by people with cancer: a qualitative study C Gratus, S Wilson, SM Greenfield, SL Damery, SA Warmington, R Grieve, ... BMC Complementary and Alternative Medicine 9, 1-7, 2009 | 115 | 2009 |
| Presystemic drug elimination PA Routledge, DG Shand Annual Review of Pharmacology and Toxicology 19 (1), 447-468, 1979 | 111 | 1979 |
